MedPath
NMPA Approval

Cadonilimab Injection

国药准字S20220018

June 28, 2022

Drug Information

卡度尼利单抗注射液

开坦尼

注射剂

125mg(10mL)/瓶

生物制品

June 28, 2022

Company Information

Applicant Company

广州市黄埔区康耀南路158号

Manufacturing Company

康方药业有限公司;中山康方生物医药有限公司

广州市黄埔区康耀南路158号;广东省中山市火炬开发区神农路6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

卡度尼利单抗注射液 - NMPA 批准文号 | MedPath